Echo Street Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Echo Street Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $866,308 - $1.28 Million	8,142 New	8,142 $932,000
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $713,584 - $934,819	7,075 New	7,075 $916,000
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $1 Million - $1.41 Million	-15,958 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $136,151 - $194,945	2,156 Added 15.62%	15,958 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $517,003 - $665,119	6,690 Added 94.07%	13,802 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $282,945 - $396,646	4,289 Added 151.93%	7,112 $658,000
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $521,321 - $651,839	-7,514 Reduced 72.69%	2,823 $219,000
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $746,848 - $1.75 Million	10,337 New	10,337 $770,000

535

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.